文化大學機構典藏 CCUR:Item 987654321/35869
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 46833/50693 (92%)
Visitors : 11854701      Online Users : 476
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: https://irlib.pccu.edu.tw/handle/987654321/35869


    Title: The in vitro and in vivo effects of the low molecular weight fucoidan on the bone osteogenic differentiation properties
    Authors: Hwang, PA (Hwang, Pai-An)
    Hung, YL (Hung, Yu-Lan)
    Phan, NN (Nam Nhut Phan)
    Hieu, BTN (Bui-Thi-Ngoc Hieu)
    Chang, PM (Chang, Po-Ming)
    Li, KL (Li, Kuan-Lun)
    Lin, YC (Lin, Yen-Chang)
    Contributors: 生科所
    Keywords: Low molecular weight fucoidan
    Osteoblast
    Aged mice
    Bone
    Mineralization
    Date: 2016-08
    Issue Date: 2017-04-12 09:25:04 (UTC+8)
    Abstract: Osteoporosis has been reported as a hidden death factor in aged people. So far, prevention and treatment therapies for osteoporosis only slow down the progress but do not treat the disease. Fucoidan has been recognized its roles in anti-tumor, anti-inflammatory, anti-coagulant and antiviral activities. To date, low molecular weight (LMW) fucoidan role in bone loss disease has been not determined yet. Therefore, this study aims to figure out potential effects of LMW fucoidan in osteoporosis in vitro and in vivo. LMW fucoidan was extracted from fresh Sargassum hemiphyllum showing a significant increase in 7F2 cell viability to 150.33 +/- 6.50 % relative to normal fucoidan (130.12 +/- 5.74 %). The expression of level BMP-2, ALP, osteocalcin significantly increased with 2.28 +/- 0.06, 2.18 +/- 0.12 and 2.06 +/- 0.07 fold, respectively. The RT-PCR assay showed that LMW fucoidan increased mRNA expression of BMP-2, ALP, osteocalcin, COL I, BSP and osteonectin. Furthermore, the bone density and bone ash weight were considerably boosted by the oral administration of 280 mg/kg LMW fucoidan and 100 mg/kg calcium carbonate in C57BL/6J female aged mice. The present finding indicated that LMW fucoidan triggered osteogenic differentiation in vitro, and had an anabolic effect on bone mineralization in vivo. Dietary intake of LMW fucoidan from S. hemiphyllum suggested playing a role in the enhancement of bone loss with increasing age.
    Relation: CYTOTECHNOLOGY 卷: 68 期: 4 頁碼: 1349-1359
    Appears in Collections:[Graduate Institute of Biotechnology ] journal articles

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML215View/Open


    All items in CCUR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback